Revolution Medicines to Participate in Cowen 42nd Annual Health Care Conference
01 mars 2022 16h05 HE
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers,...
Esperion to Participate in Upcoming Virtual Cowen 42nd Annual Healthcare Conference
24 févr. 2022 08h00 HE
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that Chief Medical Officer, Dr. JoAnne Foody, will participate in a Cardiometabolic/NASH focused panel, in...
22nd Century Group to Participate in Fireside Chat Events with Alliance Global Partners Equity Analyst Aaron Grey and Cowen Equity Analyst Vivien Azer on Wednesday, January 5, 2022
03 janv. 2022 14h23 HE
|
22nd Century Group, Inc
BUFFALO, N.Y., Jan. 03, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
CSX Chief Executive Officer to Address Cowen Global Transportation & Sustainable Mobility Conference
03 sept. 2021 10h00 HE
|
CSX Corporation
JACKSONVILLE, Fla., Sept. 03, 2021 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) President and Chief Executive Officer James M. Foote will address the Cowen 14th Annual Global Transportation &...
Mimecast to Present at Cowen’s 49th Annual Technology, Media & Telecom Conference
27 mai 2021 09h00 HE
|
Mimecast Limited
LEXINGTON, Mass., May 27, 2021 (GLOBE NEWSWIRE) -- Mimecast Limited (NASDAQ: MIME), a leading email security and cyber resilience company, today announced Chief Financial Officer Rafe Brown, will...
Revolution Medicines to Participate in Cowen 2nd Annual Virtual Oncology Innovation Summit
18 mai 2021 07h30 HE
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., May 18, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company developing targeted therapies to inhibit frontier...
Misonix to Participate in Upcoming March Investor Conferences
01 mars 2021 08h07 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., March 01, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Coherus Management to Present at Upcoming Investor Conferences
25 févr. 2021 08h45 HE
|
Coherus BioSciences, Inc.
REDWOOD CITY, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), announced today that senior management will present at the following investor conferences...
Conformis, Inc. to Participate in Upcoming Investor Conferences
25 févr. 2021 08h00 HE
|
Conformis, Inc.
BILLERICA, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today...
FibroGen to Present at Upcoming Investor Conferences
12 févr. 2021 07h00 HE
|
FibroGen, Inc
SAN FRANCISCO, Feb. 12, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Enrique Conterno, Chief Executive Officer, will participate in fireside chats at the following...